drugset / Trial / NCT03274284
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the short term results of chemoradiation in case of T1G3 BC after BCG failure.
Timeline
- Start
- 2017-10
- Primary completion
- 2019-11
- Completion
- 2019-12
Publications
- Background Lambert EH, Pierorazio PM, Olsson CA, Benson MC, McKiernan JM, Poon S. The increasing use of intravesical therapies for stage T1 bladder cancer coincides with decreasing survival after cystectomy. BJU Int. 2007 Jul;100(1):33-6. doi: 10.1111/j.1464-410X.2007.06912.x.
- Background Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol. 2002 Apr;167(4):1573-83.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |